CoChat

[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial

Open access
Wu, Xilin, Senanayake, Russell, Goodchild, Emily, Bashari, Waiel A., Salsbury, Jackie, Cabrera, Claudia P., Argentesi, Giulia, O’Toole, Samuel M., Matson, Matthew, Koo, Brendan, Parvanta, Laila, Hilliard, Nick, Kosmoliaptsis, Vasilis, Marker, Alison, Berney, Daniel M., Tan, Wilson, Foo, Roger, Mein, Charles A., Wozniak, Eva, Savage, Emmanuel, Sahdev, Anju, Bird, Nicholas, Laycock, Kate, Boros, Istvan, Hader, Stefan, Warnes, Victoria, Gillett, Daniel, Dawnay, Anne, Adeyeye, Elizabeth, Prete, Alessandro, Taylor, Angela E., Arlt, Wiebke, Bhuva, Anish N., Aigbirhio, Franklin, Manisty, Charlotte, McIntosh, Alasdair, McConnachie, Alexander, Cruickshank, J. Kennedy, Cheow, Heok, Gurnell, Mark, Drake, William M., Brown, Morris J. · 2023 · Nature Medicine
Cited by 148

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Primary aldosteronism (PA) due to a unilateral aldosterone-producing adenoma is a common cause of hypertension. This can be cured, or greatly improved, by adrenal surgery. However, the invasive nature of the standard pre-surgical investigation contributes to fewer than 1% of patients with PA being offered the chance of a cure. The primary objective of our prospective study of 143 patients with PA ( NCT02945904 ) was to compare the accuracy of a non-invasive test, [ 11 C]metomidate positron emission tomography computed tomography (MTO) scanning, with adrenal vein sampling (AVS) in predicting the biochemical remission of PA and the resolution of hypertension after surgery. A total of 128 patients reached 6- to 9-month follow-up, with 78 (61%) treated surgically and 50 (39%) managed medically. Of the 78 patients receiving surgery, 77 achieved one or more PA surgical outcome criterion for success. The accuracies of MTO at predicting biochemical and clinical success following adrenalectomy were, respectively, 72.7 and 65.4%. For AVS, the accuracies were 63.6 and 61.5%. MTO was not significantly superior, but the differences of 9.1% (95% confidence interval = −6.5 to 24.1%) and 3.8% (95% confidence interval = −11.9 to 9.4) lay within the pre-specified −17% margin for non-inferiority ( P = 0.00055 and P = 0.0077, respectively). Of 24 serious adverse events, none was considered related to either investigation and 22 were fully resolved. MTO enables non-invasive diagnosis of unilateral PA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-022-02114-5

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 148

Metadata

Authors
Wu, X., Senanayake, R., Goodchild, E., Bashari, W. A., Salsbury, J., Cabrera, C. P., Argentesi, G., O’Toole, S. M., Matson, M., Koo, B., Parvanta, L., Hilliard, N., Kosmoliaptsis, V., Marker, A., Berney, D. M., Tan, W., Foo, R., Mein, C. A., Wozniak, E., Savage, E., Sahdev, A., Bird, N., Laycock, K., Boros, I., Hader, S., Warnes, V., Gillett, D., Dawnay, A., Adeyeye, E., Prete, A., Taylor, A. E., Arlt, W., Bhuva, A. N., Aigbirhio, F., Manisty, C., McIntosh, A., McConnachie, A., Cruickshank, J. K., Cheow, H., Gurnell, M., Drake, W. M., & Brown, M. J.
Venue
Nature Medicine
Published
2023-01
Volume
29
Issue
1
Pages
190-202
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4316507584
Cited by
148
References
10
FWCI
24.32
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. https://app.cochat.ai/papers/10.1038/s41591-022-02114-5
The paper
Wu, X., Senanayake, R., Goodchild, E., Bashari, W. A., Salsbury, J., Cabrera, C. P., Argentesi, G., O’Toole, S. M., Matson, M., Koo, B., Parvanta, L., Hilliard, N., Kosmoliaptsis, V., Marker, A., Berney, D. M., Tan, W., Foo, R., Mein, C. A., Wozniak, E., . . . Brown, M. J. (2023). [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nature Medicine. https://doi.org/10.1038/s41591-022-02114-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.